- Medical School - New York University School of Medicine (2000-2004)
- Internship - University of California San Francisco School of Medicine (2004-2005), General Surgery
- Fellowship - Loma Linda University School of Medicine (2005-2006), Neurophysiology
- Residency - Loma Linda University Medical Center (2006-2009), Anesthesiology
- Fellowship - Stanford University Pain Management Center (2009-2010), Pain Management
Gerald Matchett, M.D.
- Anesthesiology And Pain Mgmt
- Pain Management
Gerald Matchett, M.D., is an Associate Professor in the Department of Anesthesiology and Pain Management at UT Southwestern Medical Center. He specializes in the evaluation, treatment, and prevention of pain.
Dr. Matchett earned his medical degree at New York University School of Medicine and completed a residency in anesthesiology at Loma Linda University. He received advanced training in neurophysiology through a fellowship at Loma Linda and in pain management through a fellowship at Stanford University.
Certified by the American Board of Anesthesiology in anesthesiology and pain medicine, he joined the UT Southwestern faculty in 2010.
Dr. Matchett serves on the residency program evaluation committee and on the resuscitation committee at Parkland Memorial Hospital. He is a member of the American Society of Anesthesiologists, the Texas Society of Anesthesiologists, and the International Anesthesia Research Society.
Dr. Matchett is the principal investigator of the EvK Clinical Trial, a study that since 2016 has examined the risks and benefits of using etomidate versus ketamine during emergency endotracheal intubation. He has published several academic articles.
In 2017, he earned the Faculty of the Year Award from the UTSW Department of Anesthesiology and Pain Management.
- American Society of Anesthesiologists (2006)
Measuring the Cost and Effect of Current Community Consultation and Public Disclosure Techniques in Emergency Care Research.
Matchett G, Ryan TJ, Sunna MC, Lee SC, Pepe PE Resuscitation 2018 Apr
Use of a Tilting Orthopedic Fracture Table to Facilitate Proper Patient Positioning During Intrathecal Neurolysis With Hyperbaric Phenol: A Case Report.
Loo NH, Matchett G A & A case reports 2017 May
Intercostal Nerve Block and Neurolysis for Intractable Cancer Pain.
Matchett G Journal of pain & palliative care pharmacotherapy 2016 Apr 1-4
How Drug Shortages Affect Clinical Care: The Case of the Surgical Anesthetic Propofol.
Romito B, Stone J, Ning N, Yin C, Llano EM, Liu J, Somanath K, Lee CT, Matchett G Hospital pharmacy 2015 Oct 50 9 798-805
Intercostal administration of liposomal bupivacaine as a prognostic nerve block prior to phenol neurolysis for intractable chest wall pain.
Yin C, Matchett G Journal of pain & palliative care pharmacotherapy 2014 Mar 28 1 33-6
General anesthesia suppresses normal heart rate variability in humans.
Matchett G, Wood P Chaos (Woodbury, N.Y.) 2014 Jun 24 2 023129
Combined ultrasound and fluoroscopic guidance for radiofrequency ablation of the obturator nerve for intractable cancer-associated hip pain.
Stone J, Matchett G Pain physician 2014 Jan-Feb 17 1 E83-7
Using pulsed radiofrequency ablation to treat pain associated with a tumor involving the brachial plexus.
Rana H, Matchett G Pain physician 2013 May-Jun 16 3 E311-4
Hydrogen gas is ineffective in moderate and severe neonatal hypoxia-ischemia rat models.
Matchett GA, Fathali N, Hasegawa Y, Jadhav V, Ostrowski RP, Martin RD, Dorotta IR, Sun X, Zhang JH Brain research 2009 Mar 1259 90-7
Neuroprotective effect of volatile anesthetic agents: molecular mechanisms.
Matchett GA, Allard MW, Martin RD, Zhang JH Neurological research 2009 Mar 31 2 128-34
Hyperbaric oxygen therapy and cerebral ischemia: neuroprotective mechanisms.
Matchett GA, Martin RD, Zhang JH Neurological research 2009 Mar 31 2 114-21
Role of histamine in brain protection in surgical brain injury in mice.
Bravo TP, Matchett GA, Jadhav V, Martin RD, Jourdain A, Colohan A, Zhang JH, Tang J Brain research 2008 Apr 1205 100-7
The effect of 2-methoxyestradiol, a HIF-1 alpha inhibitor, in global cerebral ischemia in rats.
Zhou D, Matchett GA, Jadhav V, Dach N, Zhang JH Neurological research 2008 Apr 30 3 268-71
Granulocyte-colony stimulating factor inhibits apoptotic neuron loss after neonatal hypoxia-ischemia in rats.
Yata K, Matchett GA, Tsubokawa T, Tang J, Kanamaru K, Zhang JH Brain research 2007 May 1145 227-38
The effect of granulocyte-colony stimulating factor in global cerebral ischemia in rats.
Matchett GA, Calinisan JB, Matchett GC, Martin RD, Zhang JH Brain research 2007 Mar 1136 1 200-7
Inhibition of Src tyrosine kinase and effect on outcomes in a new in vivo model of surgically induced brain injury.
Jadhav V, Matchett G, Hsu FP, Zhang JH Journal of neurosurgery 2007 Apr 106 4 680-6
Comparison of silicon-coated nylon suture to plain nylon suture in the rat middle cerebral artery occlusion model.
Shimamura N, Matchett G, Tsubokawa T, Ohkuma H, Zhang J Journal of neuroscience methods 2006 Sep 156 1-2 161-5
Inhibition of integrin alphavbeta3 ameliorates focal cerebral ischemic damage in the rat middle cerebral artery occlusion model.
Shimamura N, Matchett G, Yatsushige H, Calvert JW, Ohkuma H, Zhang J Stroke; a journal of cerebral circulation 2006 Jul 37 7 1902-9
Inhibition of integrin alphavbeta3 reduces blood-brain barrier breakdown in focal ischemia in rats.
Shimamura N, Matchett G, Solaroglu I, Tsubokawa T, Ohkuma H, Zhang J Journal of neuroscience research 2006 Dec 84 8 1837-47
Surgically induced brain injury in rats: the effect of erythropoietin.
Matchett G, Hahn J, Obenaus A, Zhang J Journal of neuroscience methods 2006 Dec 158 2 234-41
Transcriptional activation by the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen is facilitated by an N-terminal chromatin-binding motif.
Wong LY, Matchett GA, Wilson AC Journal of virology 2004 Sep 78 18 10074-85
- Measuring the Cost and Effect of Current Community Consultation and Public Disclosure Techniques in Emergency Care Research.
- Pain Management